ArticleBorderline personality disorder and emotion dysregulation2026
Transcutaneous auricular vagus nerve stimulation and emotional responding in borderline personality disorder: a randomized single-blind, sham-controlled study.
Article in Borderline personality disorder and emotion dysregulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05892900 (Transcutaneous Vagus Nerve Stimulation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Transcutaneous Vagus Nerve Stimulation (tVNS) to Acutely Reduce Emotional Vulnerability and Improve Emotional Regulation in Borderline Personality Disorder (tVNS-BPD): a Randomized, Single-blind, Sham-controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBorderline personality disorder (BPD) is characterized by severe emotional vulnerability, including heightened sensitivity, exaggerated reactivity, and delayed recovery from emotional arousal. Altered interoceptive-affective processing may contribute to these features. Transcutaneous auricular vagus nerve stimulation (taVNS) provides a non-invasive method for modulating vagal-afferent pathways involved in interoception and emotion regulation. This study examined whether active taVNS, relative to sham stimulation, was associated with lower self-reported negative affect during a video-based mood-induction paradigm in women with BPD.
methodsThirty-four female psychiatric outpatients with DSM-5 BPD were randomized to receive active taVNS or sham stimulation during a single-session experimental paradigm. Self-reported negative affect was assessed repeatedly using the Positive and Negative Affect Schedule (PANAS) Negative Affect scale. The primary analysis modeled PANAS Negative Affect across four collapsed task phases: Pre-Induction, Post-Neutral, Post-Negative, and Recovery-Negative, adjusting for baseline negative affect and stimulation intensity. Exploratory physiological analyses examined heart rate, lnRMSSD, phasic electrodermal activity (EDA) response frequency, and tonic skin conductance level.
resultsActive taVNS was associated with lower PANAS Negative Affect across the mood-induction paradigm compared with sham stimulation, Treatment Group: F(1, 36.44) = 5.74, p = 0.022. Negative affect varied significantly across task phases, F(3, 94.12) = 22.60, p < 0.001, confirming successful mood induction. The Treatment Group × Phase interaction was not significant, F(3, 94.12) = 0.75, p = 0.525. Exploratory physiological analyses showed no treatment-related effects on heart rate, lnRMSSD, or phasic EDA response frequency. Tonic skin conductance level showed no main effect of Treatment Group, but an exploratory Treatment Group × Epoch interaction.
conclusionsIn this preliminary single-session randomized sham-controlled study, active taVNS was associated with lower self-reported negative affect during a mood-induction paradigm in women with BPD. This subjective effect was not accompanied by treatment-related effects on heart rate, lnRMSSD, or phasic EDA response frequency, while the tonic skin conductance interaction should be interpreted cautiously as exploratory. These findings support further investigation of taVNS as a mechanistic probe of acute affective responding in BPD.
trial registrationClinicalTrials.gov NCT05892900. Retrospectively registered 7 June 2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.